Bispecific T cell Engagers Workshop

Sept. 30–Oct. 1, 2021 • San Diego

View Schedule • Registration Rates • Register Now

ORGANIZERS

• Elizabeth Budde, MD, PhD – City of Hope
• Daniel S. Chen, MD, PhD – IGM Biosciences, Inc.
• James L. Gulley, MD, PhD, FACP – National Cancer Institute

Overview

The Society for Immunotherapy of Cancer (SITC) invites you to attend the workshop, Bispecific T cell Engagers. This SITC workshop will focus on T cell engager biology and therapeutic strategies including target selection, therapeutic engineering and design features, cytotoxicity vs cytokine release, impact of the tumor microenvironment, and advances in conditionally-active binding.

Additionally, considerations related to dosing, schedule, sequencing and combination approaches for optimizing both endogenous and synthetic immunity will be discussed.

Target Audience

• Basic, translational and clinical researchers from academic, industry, or government settings with an interest in developing, validating and applying T cell engager therapies for cancer treatment.

Learning Objectives

• Compare and contrast cancer immunotherapy approaches employing endogenous or synthetic immunity.
• Describe the biological and engineering considerations for development of T cell engagers.
• Outline current clinical application of T cell engagers and identify challenges with their use in cancer immunotherapy.

Immediately preceding the Bispecific T cell Engagers Workshop, SITC is hosting an innovative workshop, Interrogating the Tumor-Specific Surfaceome for Immune Targeting, focused on the tumor cell surfaceome and the many opportunities that accompany it for the development of future immunotherapies and maximization of existing techniques.

A collaborative session, taking place the morning of Sept. 30, will allow attendees from both workshops to discuss alignment and debates in the areas of the two workshops with the focus on how to continue to advance the field.

It is anticipated that the efforts of these workshops will fuel innovative collaborations, disseminate important knowledge to the rest of the immunotherapy field, and help assure the continued growth of immunotherapy treatments as a whole.

Participants will receive a discount when registering for both the Bispecific T cell Engagers Workshop and the Surfaceome Workshop, which take place at the same location.

View Program Schedule

SITC is actively monitoring the incidence of COVID-19 and how it may impact our workshops. At this time, SITC is planning to host this event live (in-person) in San Diego. We will continue to assess the feasibility and safety of a live event. In the instance an in-person meeting is not feasible, the workshop will shift to a virtual format. This decision will be announced in early July 2021, and should the need arise, registrants will have the option for a refund or to convert to a virtual registration.

The Bispecific T cell Engagers Workshop is supported, in part, by educational grants from Bristol Myers Squibb, Genentech, a member of the Roche Group, Genmab US, Inc. and Pfizer, Inc. (as of 6/24/2021).

If you have questions about this program, please contact the SITC Education team.